Thomas Démoulins PhD , Kai Schulze PhD , Thomas Ebensen PhD , Navapon Techakriengkrai DVM, PhD , Teerawut Nedumpun DVM, PhD , Pavlos C. Englezou PhD , Markus Gerber Laboratory technician , Ruslan Hlushchuk MD, PhD , Darien Toledo MSc , Valentin Djonov MD, PhD , Stephan von Gunten MD, PhD , Kenneth C. McCullough PhD , Matthias Liniger PhD , Carlos A. Guzmán MD, PhD , Sanipa Suradhat DVM, PhD , Nicolas Ruggli DVM, PhD
{"title":"衣壳复制子载体:抗传染病的自我复制RNA疫苗","authors":"Thomas Démoulins PhD , Kai Schulze PhD , Thomas Ebensen PhD , Navapon Techakriengkrai DVM, PhD , Teerawut Nedumpun DVM, PhD , Pavlos C. Englezou PhD , Markus Gerber Laboratory technician , Ruslan Hlushchuk MD, PhD , Darien Toledo MSc , Valentin Djonov MD, PhD , Stephan von Gunten MD, PhD , Kenneth C. McCullough PhD , Matthias Liniger PhD , Carlos A. Guzmán MD, PhD , Sanipa Suradhat DVM, PhD , Nicolas Ruggli DVM, PhD","doi":"10.1016/j.nano.2023.102655","DOIUrl":null,"url":null,"abstract":"<div><p>Herein, we provide the first description of a synthetic delivery method for self-replicating replicon RNAs (RepRNA) derived from classical swine fever virus (CSFV) using a Coatsome-replicon vehicle based on Coatsome® SS technologies. This results in an unprecedented efficacy when compared to well-established polyplexes, with up to ∼65 fold-increase of the synthesis of RepRNA-encoded gene of interest (GOI). We demonstrated the efficacy of such Coatsome-replicon vehicles for RepRNA-mediated induction of CD8 T-cell responses in mice. Moreover, we provide new insights on physical properties of the RepRNA, showing that the removal of all CSFV structural protein genes has a positive effect on the translation of the GOI. Finally, we successfully engineered RepRNA constructs encoding a porcine reproductive and respiratory syndrome virus (PRRSV) antigen, providing an example of antigen expression with potential application to combat viral diseases. The versatility and simplicity of modifying and manufacturing these Coatsome-replicon vehicle formulations represents a major asset to tackle foreseeable emerging pandemics.</p></div>","PeriodicalId":396,"journal":{"name":"Nanomedicine: Nanotechnology, Biology and Medicine","volume":"49 ","pages":"Article 102655"},"PeriodicalIF":4.7000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases\",\"authors\":\"Thomas Démoulins PhD , Kai Schulze PhD , Thomas Ebensen PhD , Navapon Techakriengkrai DVM, PhD , Teerawut Nedumpun DVM, PhD , Pavlos C. Englezou PhD , Markus Gerber Laboratory technician , Ruslan Hlushchuk MD, PhD , Darien Toledo MSc , Valentin Djonov MD, PhD , Stephan von Gunten MD, PhD , Kenneth C. McCullough PhD , Matthias Liniger PhD , Carlos A. Guzmán MD, PhD , Sanipa Suradhat DVM, PhD , Nicolas Ruggli DVM, PhD\",\"doi\":\"10.1016/j.nano.2023.102655\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Herein, we provide the first description of a synthetic delivery method for self-replicating replicon RNAs (RepRNA) derived from classical swine fever virus (CSFV) using a Coatsome-replicon vehicle based on Coatsome® SS technologies. This results in an unprecedented efficacy when compared to well-established polyplexes, with up to ∼65 fold-increase of the synthesis of RepRNA-encoded gene of interest (GOI). We demonstrated the efficacy of such Coatsome-replicon vehicles for RepRNA-mediated induction of CD8 T-cell responses in mice. Moreover, we provide new insights on physical properties of the RepRNA, showing that the removal of all CSFV structural protein genes has a positive effect on the translation of the GOI. Finally, we successfully engineered RepRNA constructs encoding a porcine reproductive and respiratory syndrome virus (PRRSV) antigen, providing an example of antigen expression with potential application to combat viral diseases. The versatility and simplicity of modifying and manufacturing these Coatsome-replicon vehicle formulations represents a major asset to tackle foreseeable emerging pandemics.</p></div>\",\"PeriodicalId\":396,\"journal\":{\"name\":\"Nanomedicine: Nanotechnology, Biology and Medicine\",\"volume\":\"49 \",\"pages\":\"Article 102655\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanomedicine: Nanotechnology, Biology and Medicine\",\"FirstCategoryId\":\"1\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1549963423000060\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine: Nanotechnology, Biology and Medicine","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1549963423000060","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases
Herein, we provide the first description of a synthetic delivery method for self-replicating replicon RNAs (RepRNA) derived from classical swine fever virus (CSFV) using a Coatsome-replicon vehicle based on Coatsome® SS technologies. This results in an unprecedented efficacy when compared to well-established polyplexes, with up to ∼65 fold-increase of the synthesis of RepRNA-encoded gene of interest (GOI). We demonstrated the efficacy of such Coatsome-replicon vehicles for RepRNA-mediated induction of CD8 T-cell responses in mice. Moreover, we provide new insights on physical properties of the RepRNA, showing that the removal of all CSFV structural protein genes has a positive effect on the translation of the GOI. Finally, we successfully engineered RepRNA constructs encoding a porcine reproductive and respiratory syndrome virus (PRRSV) antigen, providing an example of antigen expression with potential application to combat viral diseases. The versatility and simplicity of modifying and manufacturing these Coatsome-replicon vehicle formulations represents a major asset to tackle foreseeable emerging pandemics.
期刊介绍:
Nanomedicine: Nanotechnology, Biology and Medicine (NBM) is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.